Topic: Lung cancer.
Destination: ALK Positive is partnering with the LCRF to support ALK-positive non-small cell lung cancer research. Funded research projects are expected to have a direct impact on the outcomes of patients with advanced ALK-positive lung cancer, to ultimately transform care and improve outcomes for patients with ALK-positive NSCLC.
Duration: 2 years.
Llena el siguiente formulario para recibir más información: